Search - tctmd.com

Displaying 361 - 380 of 411

Sort: Relevancy | Date

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

Manuscript

Optimizing Transcatheter Aortic Valve Implantation Could Make It Even More Cost-Effective!

October 06, 2017

Manuscript

Cost-Effectiveness and Projected Survival of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement for High Risk Patients in a European Setting: A Dutch Analysis Based on the CoreValve High Risk Trial

October 05, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

Manuscript

Cerebral Embolic Protection: Point–Counter Point

September 08, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

Manuscript

A Standardized Minimalistic Approach to Transfemoral TAVR: Cooking Up Perfection or Following One Recipe with Different Ingredients?

August 24, 2017

Manuscript

Aortic Valve Disease in the 2017 Focused Update: Questions Answered and Questions Raised

August 24, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

Manuscript

Biomarkers in Aortic Stenosis: A Systematic Review

May 31, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

Presentation SWVS 2017

Atrial Fibrillation After SAVR: Optimizing management of peri-TAVR AF

Presenter: Ankur Kalra

May 06, 2017

Presentation ACC 2017

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Michael Mack

March 20, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Three

Shelley Wood

March 19, 2017

Presentation SIF 2017

Not So Fast: SAVR Will Win

Presenter: Michael J. Reardon

March 11, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

Presentation Miami Valves 2017

Should We Worry About Transcatheter Heart Valve Durability?

Presenter: Danny Dvir

January 31, 2017

Advertisement

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Optimizing Transcatheter Aortic Valve Implantation Could Make It Even More Cost-Effective!

Cost-Effectiveness and Projected Survival of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement for High Risk Patients in a European Setting: A Dutch Analysis Based on the CoreValve High Risk Trial

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Cerebral Embolic Protection: Point–Counter Point

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

A Standardized Minimalistic Approach to Transfemoral TAVR: Cooking Up Perfection or Following One Recipe with Different Ingredients?

Aortic Valve Disease in the 2017 Focused Update: Questions Answered and Questions Raised

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Biomarkers in Aortic Stenosis: A Systematic Review

More Early Stroke With SAVR Than TAVR in SURTAVI

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Atrial Fibrillation After SAVR: Optimizing management of peri-TAVR AF

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Live From Washington: ACC 2017, Day Three

Not So Fast: SAVR Will Win

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Should We Worry About Transcatheter Heart Valve Durability?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content